Home
Dashboard
Curated content
Startups & Scaleups
Corporates
Investors
Funding rounds
Exits
Universities
Accelerators
Workspaces
Service providers
More organizations
Matching tool
Investment heatmap
Themes
Reports
Companies
ReMYND
Save
ReMYND
Developing treatments for Alzheimer’s, diabetes and other diseases caused by cellular dysfunction.
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
Recent News about ReMYND
Edit